{"id":"NCT02373371","sponsor":"University Hospital, Limoges","briefTitle":"Actinic Keratoses Treatment With Metvix® in Combination With Light","officialTitle":"Efficacy and Safety of Metvix® Natural Daylight Photodynamic Therapy Versus Conventional Metvix® Photodynamic Therapy in Subject With Mild Actinic Keratoses","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2015-03-25","primaryCompletion":"2016-11-22","completion":"2018-06-01","firstPosted":"2015-02-27","resultsPosted":"2019-04-08","lastUpdate":"2025-07-29"},"enrollment":26,"design":{"allocation":"RANDOMIZED","model":"SINGLE_GROUP","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Actinic Keratoses"],"interventions":[{"type":"DRUG","name":"Metvix®","otherNames":[]},{"type":"PROCEDURE","name":"Photodynamic Therapy Blue light","otherNames":[]},{"type":"PROCEDURE","name":"Photodynamic Therapy Daylight","otherNames":[]}],"arms":[{"label":"Daylight","type":"EXPERIMENTAL"},{"label":"Conventional treatment","type":"ACTIVE_COMPARATOR"}],"summary":"The main objective of this study is to compare efficacy and safety of Metvix® natural daylight photodynamic therapy with those of Metvix® conventional photodynamic therapy in subjects with mild actinic keratoses (intra-individual comparison)","primaryOutcome":{"measure":"Mean Change From Baseline in Total Number of Treated Mild Lesions Per Side at Week 12","timeFrame":"Baseline and Week 12","effectByArm":[{"arm":"Daylight","deltaMin":19.6,"sd":6},{"arm":"Conventional Treatment","deltaMin":20,"sd":6.9}],"pValues":[{"comp":"OG000 vs OG001","p":"0.8460"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":2,"exclusionCount":3},"locations":{"siteCount":1,"countries":["France"]},"refs":{"pmids":["31955461"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":1,"n":13},"commonTop":[]}}